421 related articles for article (PubMed ID: 26189947)
1. The chemokine CCL20 induces proinflammatory and matrix degradative responses in cartilage.
Alaaeddine N; Antoniou J; Moussa M; Hilal G; Kreichaty G; Ghanem I; Abouchedid W; Saghbini E; Di Battista JA
Inflamm Res; 2015 Sep; 64(9):721-31. PubMed ID: 26189947
[TBL] [Abstract][Full Text] [Related]
2. CCL20 stimulates proinflammatory mediator synthesis in human fibroblast-like synoviocytes through a MAP kinase-dependent process with transcriptional and posttranscriptional control.
Alaaeddine N; Hilal G; Baddoura R; Antoniou J; Di Battista JA
J Rheumatol; 2011 Sep; 38(9):1858-65. PubMed ID: 21724701
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of hsa-miR-148a promotes cartilage production and inhibits cartilage degradation by osteoarthritic chondrocytes.
Vonk LA; Kragten AH; Dhert WJ; Saris DB; Creemers LB
Osteoarthritis Cartilage; 2014 Jan; 22(1):145-53. PubMed ID: 24269634
[TBL] [Abstract][Full Text] [Related]
4. Enhanced suppressor of cytokine signaling 3 in arthritic cartilage dysregulates human chondrocyte function.
van de Loo FA; Veenbergen S; van den Brand B; Bennink MB; Blaney-Davidson E; Arntz OJ; van Beuningen HM; van der Kraan PM; van den Berg WB
Arthritis Rheum; 2012 Oct; 64(10):3313-23. PubMed ID: 22576756
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-558 regulates the expression of cyclooxygenase-2 and IL-1β-induced catabolic effects in human articular chondrocytes.
Park SJ; Cheon EJ; Kim HA
Osteoarthritis Cartilage; 2013 Jul; 21(7):981-9. PubMed ID: 23611898
[TBL] [Abstract][Full Text] [Related]
6. Production of the chemokine RANTES by articular chondrocytes and role in cartilage degradation.
Alaaeddine N; Olee T; Hashimoto S; Creighton-Achermann L; Lotz M
Arthritis Rheum; 2001 Jul; 44(7):1633-43. PubMed ID: 11465714
[TBL] [Abstract][Full Text] [Related]
7. Stigmasterol: a phytosterol with potential anti-osteoarthritic properties.
Gabay O; Sanchez C; Salvat C; Chevy F; Breton M; Nourissat G; Wolf C; Jacques C; Berenbaum F
Osteoarthritis Cartilage; 2010 Jan; 18(1):106-16. PubMed ID: 19786147
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin PGE2 at very low concentrations suppresses collagen cleavage in cultured human osteoarthritic articular cartilage: this involves a decrease in expression of proinflammatory genes, collagenases and COL10A1, a gene linked to chondrocyte hypertrophy.
Tchetina EV; Di Battista JA; Zukor DJ; Antoniou J; Poole AR
Arthritis Res Ther; 2007; 9(4):R75. PubMed ID: 17683641
[TBL] [Abstract][Full Text] [Related]
9. Activation of matrix metalloproteinases 2, 9, and 13 by activated protein C in human osteoarthritic cartilage chondrocytes.
Jackson MT; Moradi B; Smith MM; Jackson CJ; Little CB
Arthritis Rheumatol; 2014 Jun; 66(6):1525-36. PubMed ID: 24574263
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of periostin in human osteoarthritic cartilage and its potential role in matrix degradation via matrix metalloproteinase-13.
Attur M; Yang Q; Shimada K; Tachida Y; Nagase H; Mignatti P; Statman L; Palmer G; Kirsch T; Beier F; Abramson SB
FASEB J; 2015 Oct; 29(10):4107-21. PubMed ID: 26092928
[TBL] [Abstract][Full Text] [Related]
11. Lentiviral vector-mediated shRNAs targeting a functional isoform of the leptin receptor (Ob-Rb) inhibit cartilage degeneration in a rat model of osteoarthritis.
Deng SL; Zhu J; Huang Q; Fu WL; Li Q; Chen G; Tang X; Li J
Osteoarthritis Cartilage; 2017 Nov; 25(11):1912-1921. PubMed ID: 28823646
[TBL] [Abstract][Full Text] [Related]
12. A global increase in 5-hydroxymethylcytosine levels marks osteoarthritic chondrocytes.
Taylor SE; Smeriglio P; Dhulipala L; Rath M; Bhutani N
Arthritis Rheumatol; 2014 Jan; 66(1):90-100. PubMed ID: 24449578
[TBL] [Abstract][Full Text] [Related]
13. Activation of cartilage matrix metalloproteinases by activated protein C.
Jackson MT; Smith MM; Smith SM; Jackson CJ; Xue M; Little CB
Arthritis Rheum; 2009 Mar; 60(3):780-91. PubMed ID: 19248107
[TBL] [Abstract][Full Text] [Related]
14. Alterations of high-mannose type N-glycosylation in human and mouse osteoarthritis cartilage.
Urita A; Matsuhashi T; Onodera T; Nakagawa H; Hato M; Amano M; Seito N; Minami A; Nishimura S; Iwasaki N
Arthritis Rheum; 2011 Nov; 63(11):3428-38. PubMed ID: 21834068
[TBL] [Abstract][Full Text] [Related]
15. Increased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritis.
Chan BY; Fuller ES; Russell AK; Smith SM; Smith MM; Jackson MT; Cake MA; Read RA; Bateman JF; Sambrook PN; Little CB
Osteoarthritis Cartilage; 2011 Jul; 19(7):874-85. PubMed ID: 21619935
[TBL] [Abstract][Full Text] [Related]
16. Phase 2 enzyme inducer sulphoraphane blocks prostaglandin and nitric oxide synthesis in human articular chondrocytes and inhibits cartilage matrix degradation.
Kim HA; Yeo Y; Jung HA; Jung YO; Park SJ; Kim SJ
Rheumatology (Oxford); 2012 Jun; 51(6):1006-16. PubMed ID: 22332123
[TBL] [Abstract][Full Text] [Related]
17. Identification of opticin, a member of the small leucine-rich repeat proteoglycan family, in human articular tissues: a novel target for MMP-13 in osteoarthritis.
Monfort J; Tardif G; Roughley P; Reboul P; Boileau C; Bishop PN; Pelletier JP; Martel-Pelletier J
Osteoarthritis Cartilage; 2008 Jul; 16(7):749-55. PubMed ID: 18164633
[TBL] [Abstract][Full Text] [Related]
18. Modulation of TGF-beta signaling by proinflammatory cytokines in articular chondrocytes.
Roman-Blas JA; Stokes DG; Jimenez SA
Osteoarthritis Cartilage; 2007 Dec; 15(12):1367-77. PubMed ID: 17604656
[TBL] [Abstract][Full Text] [Related]
19. ADAM-12 (meltrin alpha) is involved in chondrocyte proliferation via cleavage of insulin-like growth factor binding protein 5 in osteoarthritic cartilage.
Okada A; Mochizuki S; Yatabe T; Kimura T; Shiomi T; Fujita Y; Matsumoto H; Sehara-Fujisawa A; Iwamoto Y; Okada Y
Arthritis Rheum; 2008 Mar; 58(3):778-89. PubMed ID: 18311789
[TBL] [Abstract][Full Text] [Related]
20. Human osteoarthritic cartilage shows reduced in vivo expression of IL-4, a chondroprotective cytokine that differentially modulates IL-1β-stimulated production of chemokines and matrix-degrading enzymes in vitro.
Assirelli E; Pulsatelli L; Dolzani P; Platano D; Olivotto E; Filardo G; Trisolino G; Facchini A; Borzì RM; Meliconi R
PLoS One; 2014; 9(5):e96925. PubMed ID: 24819779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
